Elanco reports FDA confirmation that Bovaer meets safety, efficacy requirements

Elanco announced the FDA has completed its multi-year review of Bovaer, a methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle. “This monumental announcement has the ability to accelerate the opportunity for climate-neutral dairy farming while creating a new revenue stream for dairy farmers across the country,” said Jeff Simmons, President and CEO, Elanco Animal Health. “We appreciate FDA’s commitment to maintaining high standards for science-based review, while balancing the need to quickly bring solutions to the market. Bovaer represents another example of Elanco being a partner of choice in animal health, where the capabilities of our talented R&D, regulatory and commercial teams are delivering significant value.